Overview

Evaluation of Dexketoprofen in Total Knee Arthroplasty

Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions. Dexketoprofen is a new NSAID treating acute postoperative pain. The purpose of this study is to evaluate the analgesic effect when it is given intravenously or as part of the local infiltration analgesia in patients under spinal anesthesia undergoing unilateral total knee arthroplasty.
Phase:
Phase 2
Details
Lead Sponsor:
KAT General Hospital
Treatments:
Dexketoprofen trometamol
Ropivacaine